Earlier this year, the company also reported positive results from the FLOW trial of semaglutide in patients with type 2 diabetes and CKD, showing that it slashed the risk of major cardiovascular ...
Medscape Medical News, September 23, 2024 EASD 2024 Combining Semaglutide and Mineralocorticoids May Improve CKD A FLOW subanalysis suggested the benefits of combination, but some questioned the ...
Hosted on MSN1mon
Ozempic Now FDA-Approved for Kidney Disease-Here's What to KnowGLP-1 medications are renowned for their ability to treat type 2 diabetes and aid weight loss. Now, there's a new benefit to taking Ozempic: It may help manage chronic kidney disease (CKD).
EASD 2024 Combining Semaglutide and Mineralocorticoids May Improve CKD A FLOW subanalysis suggested the benefits of combination, but some questioned the rationale. Medscape Medical News ...
The approval gives Ozempic (semaglutide) the broadest label ... disease in adults with type 2 diabetes and chronic kidney disease (CKD). "This approval for Ozempic allows us to more broadly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback